TMB or not TMB as a biomarker: That is the question-Reference-Cited by-同舟云学术

TMB or not TMB as a biomarker: That is the question

Published:2021-07 Issue: Volume:163 Page:103374
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Addeo Alfredo^ORCID,Friedlaender Alex,Banna Giuseppe L.,Weiss Glen J.^ORCID

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference69 articles.

1. Promising predictors of checkpoint inhibitor response in NSCLC;Alex;Expert Rev. Anticancer Ther.,2020

2. Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations;Allegretti;J. Exp. Clin. Cancer Res.,2018

3. Pembrolizumab in microsatellite-instability–High advanced colorectal Cancer;André;N. Engl. J. Med.,2020

4. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial;Balar;Lancet,2017

5. The promise of digital biopsy for the prediction of tumor molecular features and clinical outcomes associated with immunotherapy;Banna;Front. Med. (Lausanne),2019

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive prognostic and immunological implications of PFKP in pan-cancer;Cancer Cell International;2024-09-09

2. Combined tumour-infiltrating lymphocytes and microsatellite instability status as prognostic markers in colorectal cancer – Authors' reply;The Lancet Gastroenterology & Hepatology;2024-09

3. A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients;International Journal of Molecular Sciences;2024-08-28

4. Integrating Bulk and Single-Cell RNA-Seq Data to Identify Prognostic Features Related to Activated Dendritic Cells in Clear-Cell Renal-Cell Carcinoma;International Journal of Molecular Sciences;2024-08-26

5. Machine learning developed a macrophage signature for predicting prognosis, immune infiltration and immunotherapy features in head and neck squamous cell carcinoma;Scientific Reports;2024-08-22